BOSTON – For those in obesity treatment, things are looking up, said Reem Z. Sharaiha, MD, MSc, in a video interview at the AGA Tech Summit, sponsored by the AGA Center for GI Innovation and Technology. There are several new therapies to choose from, said Dr. Sharaiha, assistant professor of medicine at Cornell University, New York – and a variety of therapies coming down the pipeline. The key is to choose the right treatment, or right combination of treatments – surgical, endoscopic, or medical – for the right patient at the right time and to follow up. Obesity is a chronic disease that needs long-term, team treatment. With obesity treatments there is sometimes a trade-off between risk and results, but the innovations coming along may balance that risk-results equation for some patients, she said.
AGA Tech Summit
VIDEO: It is an exciting time in obesity treatment
Publish date: March 23, 2018
REPORTING FROM 2018 AGA TECH SUMMIT
Vidyard Video
More Obesity News
- Triple-agonist retatrutide hits new weight loss highs
- Half of teens drop below obesity cutoff with semaglutide
- Obesity drug with swallowable balloon boosts weight loss
- How BMI over time impacts GI cancer risk
- Endoscopic sleeve gastroplasty plus obesity drugs add up to more weight loss
- Bariatric surgery cuts risk for obesity-related cancers in half: Study
- Optimal time period for weight loss drugs: Debate continues
- Should GI own the obesity field?
AGA Update: Bariatric surgery in patients with cirrhosis
Question 1 of 4